English  |  正體中文  |  简体中文  |  总笔数 :2826152  
造访人次 :  31802687    在线人数 :  1485
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"yang j c h"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 201-210 / 428 (共43页)
<< < 16 17 18 19 20 21 22 23 24 25 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2020-12-02T02:33:26Z Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; Pan-Chyr Yang; Shih J.-Y.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏 2020-12-02T02:33:23Z Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; Yu K.-L.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Pan-Chyr Yang; Chen L.-Y.; PAN-CHYR YANG et al.
臺大學術典藏 2020-12-02T02:33:23Z The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients Wu S-G.; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; Pan-Chyr Yang; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.; Wu S-G.; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; PAN-CHYR YANG; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.
臺大學術典藏 2020-12-02T02:33:19Z Randomized phase II trial of gefitinib with and without pemetrexed as first-line therapy in patients with advanced nonsquamous non-small-cell lung cancer with activating epidermal growth factor receptor mutations Cheng Y.; Murakami H.; Pan-Chyr Yang; He J.; Nakagawa K.; Kang J.H.; Kim J.-H.; Wang X.; Enatsu S.; Puri T.; Orlando M.; Yang J.C.-H.; Cheng Y.; PAN-CHYR YANG et al.
臺大學術典藏 2020-12-02T02:33:15Z Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors Chang I.-S.; Jiang S.S.; Yang J.C.-H.; Su W.-C.; Chien L.-H.; Hsiao C.-F.; Lee J.-H.; Chen C.-Y.; Chen C.-H.; Chang G.-C.; Wang Z.; Lo F.-Y.; Chen K.-Y.; Wang W.-C.; Chen Y.-M.; Huang M.-S.; Tsai Y.-H.; Su Y.-C.; Hsieh W.-S.; Shih W.-C.; Shieh S.-H.; Yang T.-Y.; Lan Q.; Rothman N.; Chen C.-J.; Chanock S.J.; Pan-Chyr Yang; Hsiung C.A.; Chang I.-S.; PAN-CHYR YANG et al.
臺大學術典藏 2020-12-02T02:33:12Z Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery Yang W.-C.; Xiao F.; Shih J.-Y.; Ho C.-C.; Chen Y.-F.; Tseng H.-M.; Chen K.-Y.; Liao W.-Y.; Yu C.-J.; Yang J.C.-H.; Kuo S.-H.; Cheng J.C.-H.; PAN-CHYR YANG; Hsu F.-M.
臺大學術典藏 2020-12-02T02:33:06Z Precision Management of Advanced Non-Small Cell Lung Cancer Yang C.-Y.;Yang J.C.-H.;Pan-Chyr Yang; Yang C.-Y.; Yang J.C.-H.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:33:06Z A Randomized Phase 2 Study of Gefitinib With or Without Pemetrexed as First-line Treatment in Nonsquamous NSCLC With EGFR Mutation: Final Overall Survival and Biomarker Analysis Yang J.C.-H.; PAN-CHYR YANG et al.; Yang J.C.-H.; Cheng Y.; Murakami H.; Pan-Chyr Yang; He J.; Nakagawa K.; Kang J.H.; Kim J.-H.; Hozak R.R.; Nguyen T.S.; Zhang W.L.; Enatsu S.; Puri T.; Orlando M.
臺大學術典藏 2020-11-30T07:35:48Z Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis Hsu C.-L.;Jen-Hau Chen;Chen K.-Y.;Shih J.-Y.;Yang J.C.H.;Yu C.-J.;Yang P.-C.; Hsu C.-L.; JEN-HAU CHEN; Chen K.-Y.; Shih J.-Y.; Yang J.C.H.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2020-10-06T03:31:13Z Esomeprazole-induced Stevens-Johnson syndrome in a patient who underwent nivolumab therapy for advanced lung adenocarcinoma Lin Y.-T.;Yang J.C.-H.;Chia-Yu Chu; Lin Y.-T.; Yang J.C.-H.; CHIA-YU CHU

显示项目 201-210 / 428 (共43页)
<< < 16 17 18 19 20 21 22 23 24 25 > >>
每页显示[10|25|50]项目